Skip to content
10-Q

Quarterly Report

PSS WORLD MEDICAL INC

0001193125-12-457599

← back to feed
Filed
Nov 7, 2012 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2012 · Nov 2, 2012 50.32M sh
Shares Diluted Q2 2012 · Sep 28, 2012 50.07K sh
Shares Diluted Q2 2012 · Sep 28, 2012 50.17K sh
Shares Diluted restated Q2 2012 · Sep 30, 2011 53.96K sh
Shares Diluted restated Q2 2012 · Sep 30, 2011 55.67K sh
Stock Repurchased Q2 2012 · Sep 28, 2012 $7.74M
Stock Repurchased Q2 2012 · Sep 30, 2011 $80.91M
Capex Q2 2012 · Sep 28, 2012 $11.03M
Capex restated Q2 2012 · Sep 30, 2011 $9.69M
Operating Cash Flow Q2 2012 · Sep 28, 2012 $48.46M
Operating Cash Flow Q2 2012 · Sep 30, 2011 $57.48M
Short Term Debt Q2 2012 · Sep 28, 2012 $0
Short Term Debt Q2 2012 · Mar 30, 2012 $0
Cash And Equivalents Q2 2012 · Sep 28, 2012 $122.35M
Cash And Equivalents Q2 2012 · Mar 30, 2012 $163.15M
Cash And Equivalents Q2 2012 · Sep 30, 2011 $34.85M
Cash And Equivalents Q2 2012 · Apr 1, 2011 $29.35M
Stockholders Equity Q2 2012 · Sep 28, 2012 $407.6M
Stockholders Equity Q2 2012 · Mar 30, 2012 $387.13M
Current Liabilities Q2 2012 · Sep 28, 2012 $227.99M
Current Liabilities Q2 2012 · Mar 30, 2012 $201.81M
Total Liabilities Q2 2012 · Sep 28, 2012 $800.77M
Total Liabilities Q2 2012 · Mar 30, 2012 $765.16M
Current Assets Q2 2012 · Sep 28, 2012 $816.12M
Current Assets Q2 2012 · Mar 30, 2012 $821.46M
Total Assets Q2 2012 · Sep 28, 2012 $1.21B
Total Assets Q2 2012 · Mar 30, 2012 $1.16B
Eps Diluted Q2 2012 · Sep 28, 2012 $0.30
Eps Diluted Q2 2012 · Sep 28, 2012 $0.52
Eps Diluted Q2 2012 · Sep 30, 2011 $0.37
Eps Diluted Q2 2012 · Sep 30, 2011 $0.61
Eps Basic Q2 2012 · Sep 28, 2012 $0.31
Eps Basic Q2 2012 · Sep 28, 2012 $0.53
Eps Basic Q2 2012 · Sep 30, 2011 $0.38
Eps Basic Q2 2012 · Sep 30, 2011 $0.64
Sga Expense Q2 2012 · Sep 28, 2012 $78.27M
Sga Expense Q2 2012 · Sep 28, 2012 $157.95M
Sga Expense restated Q2 2012 · Sep 30, 2011 $67.66M
Sga Expense restated Q2 2012 · Sep 30, 2011 $139.61M
Net Income Q2 2012 · Sep 28, 2012 $15.27M
Net Income Q2 2012 · Sep 28, 2012 $26.01M
Net Income Q2 2012 · Sep 30, 2011 $20.03M
Net Income Q2 2012 · Sep 30, 2011 $34.22M
Operating Income Q2 2012 · Sep 28, 2012 $26.97M
Operating Income Q2 2012 · Sep 28, 2012 $48.23M
Operating Income restated Q2 2012 · Sep 30, 2011 $30.04M
Operating Income restated Q2 2012 · Sep 30, 2011 $50.01M
Gross Profit Q2 2012 · Sep 28, 2012 $142.18M
Gross Profit Q2 2012 · Sep 28, 2012 $278.47M
Gross Profit restated Q2 2012 · Sep 30, 2011 $129.93M
Gross Profit restated Q2 2012 · Sep 30, 2011 $252.6M
Cost Of Revenue Q2 2012 · Sep 28, 2012 $278.62M
Cost Of Revenue Q2 2012 · Sep 28, 2012 $551.72M
Cost Of Revenue restated Q2 2012 · Sep 30, 2011 $261.78M
Cost Of Revenue restated Q2 2012 · Sep 30, 2011 $519.6M
Revenue Q2 2012 · Sep 28, 2012 $420.8M
Revenue Q2 2012 · Sep 28, 2012 $830.19M
Revenue restated Q2 2012 · Sep 30, 2011 $391.71M
Revenue restated Q2 2012 · Sep 30, 2011 $772.2M